Expansion Plan for Clinical Trial Navigator
Expansion Readiness
| Prerequisites for Expansion |
Status |
Target |
Notes |
| Product-Market Fit in core market |
✓ Achieved |
D30 retention >35% |
Must achieve before expansion |
| Unit economics proven |
✓ Proven |
LTV:CAC >3:1 |
Sustainable in core market |
| Operational processes established |
✓ Established |
Scalable systems |
Can be replicated |
| Team capacity |
✓ Available |
Dedicated resources |
Need bandwidth for expansion |
| Capital/runway |
✓ Secured |
12+ months |
Fund expansion activities |
Geographic Expansion
Phase 1: English-Speaking Countries
Phase 2: European Countries
- Germany
- France
- Netherlands
Market Expansion
Expand to new patient segments, including those with rare diseases and chronic conditions.
- Rare disease communities
- Chronic condition support groups
- Online health forums
Business Model Expansion
Explore new revenue streams through partnerships with pharmaceutical companies and research institutions.
- Pharmaceutical company partnerships
- Research institution collaborations
- Data analytics services
12-Month Expansion Roadmap
- Months 1-3: Establish partnerships with patient advocacy groups
- Months 4-6: Launch Phase 1 geographic expansion
- Months 7-9: Develop and launch new features for market expansion
- Months 10-12: Analyze results and plan for future expansion
Revenue Projections
| Timeframe |
USA |
UK/CA/AU |
EU |
Total |
| Month 6 |
$100,000 |
$20,000 |
$0 |
$120,000 |
| Month 12 |
$200,000 |
$50,000 |
$20,000 |
$270,000 |
Expansion Risks and Mitigations
| Risk |
Mitigation |
| Regulatory challenges |
Establish relationships with regulatory bodies |
| Market competition |
Differentiate through patient-centric approach |
| Technical issues |
Invest in robust infrastructure and maintenance |
Expansion Success Metrics
- Monthly active users
- Trial matches per user
- Click-through to trial coordinator contact
- Premium conversion rate
- Patient enrollment attribution (B2B)